Last week, the VANGUARD consortium gathered for the final time in person before the conclusion of the project in June 2025. The two-day face-to-face meeting took place on 28-29 April at Lyon University in France and was hosted by the
On 25-26 January 2024, the biannual VANGUARD General Assembly took place in Innsbruck-Igls, Austria. Seventeen representatives from the consortium’s eight project partners gathered for a two-day event focused on project updates, planning, and discussions. The meeting was kindly hosted by
On 14th November 2024, the University of Geneva (UNIGE) hosted Diabetes Days 2024, an event dedicated to raising awareness about diabetes and highlighting advancements in research. Organised by the Faculty of Medicine and the Department of Cell Physiology and Metabolism,
On Monday, 16th December 2024, VANGUARD partners from the Transplantation Department at Lyon Claude Bernard University and Edouard Herriot University Hospital participated in the 6th Lyon Immunopathology Federation (LIFe) seminar held in Lyon, France. The event brought together physicians, immunology
Today, on World Diabetes Day, we emphasise the importance of open communication with patients and advocacy groups. Each November, VANGUARD partners connect, listen, and share progress with our community. This year, our partners are participating in three special patient-oriented events
A new VANGUARD article titled “The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands” has been published in the Journal of Clinical & Translational Endocrinology. This publication is openly accessible online here. In their
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874700